Evidence map›Paper›PMID 38742711›Full record

ReviewThe journals of gerontology. Series A, Biological sciences and medical sciences2024

Recommendations on Methods for Assessing Multimorbidity Changes Over Time: Aligning the Method to the Purpose.

Corey L Nagel, Nicholas J Bishop, Anda Botoseneanu, Heather G Allore, Jason T Newsom, David A Dorr, Ana R Quiñones

Abstract readReview
In one paragraph

Review in The journals of gerontology. Series A, Biological sciences and medical sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Dynamics of multimorbidity, health expectancy, and survival in middle aged and older individuals.The journals of gerontology. Series A, Biological sciences and medical sciences · 2025
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Corey L NagelCollege of Nursing, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.ORCID 0000-0003-3725-500X
Nicholas J BishopNorton School of Family and Consumer Sciences, University of Arizona, Tucson, Arizona, USA.
Anda BotoseneanuDepartment of Health & Human Services, University of Michigan, Dearborn, Michigan, USA.ORCID 0000-0003-0628-5820
Heather G AlloreDepartment of Biostatistics, Yale University, New Haven, Connecticut, USA.ORCID 0000-0001-7685-8175
Jason T NewsomDepartment of Psychology, Portland State University, Portland, Oregon, USA.
David A DorrDepartment of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, Portland, Oregon, USA.ORCID 0000-0003-2318-7261
Ana R QuiñonesDepartment of Family Medicine, Oregon Health & Science University, Portland, Oregon, USA.ORCID 0000-0001-6554-7734

Funding

Yale Study Support Suite (YES3): Dashboard and Web Portal Software Supporting Research Workflow through integrated, customizable REDCap External ModulesP30AG021342 · NIA · YALE UNIVERSITY · PI Denise Esserman · 2002 to 2026
$37.9M
Yale Alzheimer Disease Research CenterP30AG066508 · NIA · YALE UNIVERSITY · PI STEPHEN M STRITTMATTER · 2020 to 2026
$30.2M
Preparing For What Is Next With Aducanumab In Real World SettingsR33AG057806 · NIA · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Christopher Barrett Bowling, Ana Roman Quinones · 2018 to 2026
$9.0M
Multimorbidity Combinations and Dementia Onset Among Race/Ethnic Older AdultsRF1AG058545 · NIA · OREGON HEALTH & SCIENCE UNIVERSITY · PI QUINONES, ANA ROMAN · 2019 to 2019
$3.6M
Changes in Multimorbidity and Disability Among Race/Ethnic Older Adults (Administrative Supplement)R01AG055681 · NIA · OREGON HEALTH & SCIENCE UNIVERSITY · PI QUINONES, ANA ROMAN · 2017 to 2021
$2.8M
NIA NIH HHS P30 AG021342NIA NIH HHS P30 AG066508NIA NIH HHS R01 AG055681NIA NIH HHS R33 AG057806NIA NIH HHS RF1 AG058545NIH HHS R01AG055681Yale Claude D. Pepper Older Americans Independence Center P30AG021342
6 · The paper itself

Abstract

backgroundThe rapidly growing field of multimorbidity research demonstrates that changes in multimorbidity in mid- and late-life have far reaching effects on important person-centered outcomes, such as health-related quality of life. However, there are few organizing frameworks and comparatively little work weighing the merits and limitations of various quantitative methods applied to the longitudinal study of multimorbidity.

methodsWe identify and discuss methods aligned to specific research objectives with the goals of (i) establishing a common language for assessing longitudinal changes in multimorbidity, (ii) illuminating gaps in our knowledge regarding multimorbidity progression and critical periods of change, and (iii) informing research to identify groups that experience different rates and divergent etiological pathways of disease progression linked to deterioration in important health-related outcomes.

resultsWe review practical issues in the measurement of multimorbidity, longitudinal analysis of health-related data, operationalizing change over time, and discuss methods that align with 4 general typologies for research objectives in the longitudinal study of multimorbidity: (i) examine individual change in multimorbidity, (ii) identify subgroups that follow similar trajectories of multimorbidity progression, (iii) understand when, how, and why individuals or groups shift to more advanced stages of multimorbidity, and (iv) examine the coprogression of multimorbidity with key health domains.

conclusionsThis work encourages a systematic approach to the quantitative study of change in multimorbidity and provides a valuable resource for researchers working to measure and minimize the deleterious effects of multimorbidity on aging populations.

Indexed as

MultimorbidityAgedDisease ProgressionHumansLongitudinal StudiesQuality of LifeDisease progressionMethodologyMultiple chronic diseases

Identifiers

PMID38742711
PMCPMC11163923

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.